UPDATE 2-Impax Labs on the hunt after striking two deals worth $700 mln

Oct 9 (Reuters) - Impax Laboratories Inc said it was on the hunt for further deals - and would consider a so-called "tax inversion" transaction - after its acquisition of two privately held Pennsylvania drugmakers for $700 million.